This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Obesity Science & Innovation USA (OSI USA)
September 23-24, 2026
Hynes Convention CenterBoston, United States
Book Now
Menu
Book
September 23-24, 2026
Hynes Convention Center,
Boston, United States

From Innovation to Impact: Understand Leading and Emerging Obesity Therapeutics That are Transforming Lives and Reshaping Global Wellness

Delve into cutting-edge obesity research and metabolic health advancements.

Explore clinical advances in incretin-based therapeutics, as well as breakthroughs in RNA-focused and adipose-targeted approaches. Connect with experts tackling obesity's most pressing challenges, from muscle preservation and weight-maintenance to pricing and access barriers.

View Full AgendaRegister By June 5 to Save up to $1400

The OSI USA Agenda is now live!

Our agenda is live! Discover the incredible lineup of confirmed speakers, get an exclusive sneak peek into the sessions, and experience the excitement building for the event.

View Agenda

Focused Discussions to Drive Obesity Science & Innovation

+

Attendees

+

Expert Speakers

+

Partnering Hours

A Snapshot of the 2025 Agenda

scientist holding a petri dish working on obesity therapeutics

Clinical Insights on Incretin-Based Therapies

Exploring updates from leading GLP-1, and combination agonist clinical trials, across peptide and small molecule drug modalities.

photo of cells including mitochondrial uncouplers and browning agents.

RNA-Based Approaches

Exploring RNA-based approaches for obesity, including siRNA and non-coding RNA technologies.

cluster of cells for obesity research

Apidose Targeted Therapies

Discovering the latest approaches to modulate energy expenditure, including mitochondrial uncouplers and browning agents.

a measuring tape wrapped around some injectables for obesity therapeutics

Muscle Preservation Frontiers (New for 2026)

Diving into emerging approaches to combat muscle-mass loss in obesity patients, including SAR modulation and precision antibody strategies.

obesity pulls under a microscope

GLP-1s Beyond Obesity (New for 2026)

Highlighting emerging applications of GLP-1-based therapeutics for wider indications, such as osteoarthritis, Alzheimer's disease and womens health.

a single strand RNA

Innovation Spotlight

Showcasing next-generation modalities and approaches in obesity therapeutics, hear from emerging early-stage innovators who are looking at solutions

View Preliminary Agenda

Engage Qualified Decision-Makers Across the Obesity Therapeutics Landscape!

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your sales and marketing goals.

To learn more about sponsorship opportunities, contact Roshni Shah:

📧RShah@informaconnectls.com

View Sponsorship Prospectus

FAQs

expand_less

What is Obesity Science & Innovation USA (OSI USA)?

OSI USA is the premier annual conference bringing together over 150 leading experts in obesity and metabolic health to shape the future of emerging obesity therapeutics. Attendees will have the opportunity to explore groundbreaking advancements in obesity research and metabolic health, diving deep into the latest innovations and clinical insights.


Discover cutting-edge developments in GLP-1 therapies, anti-obesity medications, RNA-based approaches, adipose-targeted treatments, and muscle preservation strategies. Gain valuable clinical perspectives on incretin-based therapies, mitochondrial uncouplers, and next-generation solutions revolutionizing the science of obesity and metabolism. Join us to stay at the forefront of this transformative field.